Trulieve Announces May 2022 Event Participation
TALLAHASSEE, Fla., May 4, 2022 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced planned event participation in May.
- Regenerative Cannabis Live, May 5, 2022: Founder and CEO Kim Rivers will participate in a keynote speech and panel discussion. Event details may be found here: https://regenerativecannabislive.com/
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.
Facebook: @TrulieveInstagram: @Trulieve_ Twitter: @Trulieve
Investor ContactChristine Hersey, Executive Director of Investor Relations+1 (424) 202-0210[email protected]
Media ContactRob Kremer, Executive Director of Corporate Communications+1 (404) 218-3077[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-may-2022-event-participation-301539180.html
SOURCE Trulieve Cannabis Corp.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADLM 2026 to explore diabetes milestones, space diagnostics, Alzheimer's and Down syndrome linkages, and advances in cancer screening and biomarkers
- HANDCRAFT ENTERTAINMENT PARTNERS WITH TAKASAGO TO DEVELOP FRAGRANCES, FLAVORS, AND CONSUMER PRODUCTS TO DEFINE THE WORLD OF "GLOBAL" J-POP
- Azitra, Inc. Announces Breakthough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Increased Distribution and Elasticity
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share